<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present the case of an 11-year-old boy with humoral <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> on monthly intravenous immunoglobulins (IVIG) infusions, evaluated for recurrent, brief, neurological deficits secondary to cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> without any identifiable <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> state </plain></SENT>
<SENT sid="1" pm="."><plain>Etiologic possibilities for the thrombotic event are presented with special discussion of IVIG-related <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To the best of our knowledge, our patient represents the first reported case of Bruton's disease on IVIG therapy developing a cerebral ischemic event and the second reported case of cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with IVIG use for any disease </plain></SENT>
<SENT sid="3" pm="."><plain>Potential concerns regarding the risk of <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> during IVIG therapy in this and other disorders are reviewed </plain></SENT>
</text></document>